Lung Cancer Summit

Virtual Live Conference

October 13, 2021

Live from Geneva

Sign Up Now

Welcome to the

International Lung Cancer Summit

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse laoreet erat augue, ac venenatis nunc pulvinar nec. Donec lorem diam, lobortis ut eros in, placerat cursus quam.

Registration open on (To update), 2021

Ut mollis pulvinar nibh venenatis placerat. Aliquam ipsum ipsum, tincidunt at diam a, vehicula dignissim est. Nunc pulvinar velit quis mi cursus, vel facilisis est posuere. Sed posuere vitae nibh a sagittis. Donec nisi sapien, viverra et viverra et, venenatis ac turpis.

Our Chairs Invite You To Join


Alfredo Addeo

Alfredo Addeo, MD, is a Consultant Medical Oncologist at the University Hospital of Geneva, Switzerland. He is the author of numerous national and international peer-reviewed publications in renowned scientific journals, including first- and last-author publications in the Journal of Clinical Oncology, Annals of Oncology and Lancet Oncology. He has acted as a reviewer for several international scientific journals, including Journal of Thoracic Oncology and JAMA Oncology, and is an associate editor for Frontiers in Thoracic Oncology and guest editor for Precision Cancer Medicine. Dr. Addeo is an active ESMO member and a member of the EORTC lung group. He actively participates in ETOP (European Thoracic Oncology Platform) and SAKK (the Swiss Group for Clinical Cancer Research) and is a researcher and co-investigator of several national and international studies.

Don’t miss the WestWind podcast with Dr. Jack West hosting Dr. Addeo to learn more about his path and challenges from Italy over UK to Switzerland.

Photo of Solange Peters

Solange Peters

Solange Peters, MD, PhD, is Professor and chair of Medical Oncology as well as the Thoracic Malignancies programme in the department of oncology at the University Hospital of Lausanne, Switzerland. She has authored numerous peer-reviewed manuscripts and book chapters, and serves as deputy editor of the Journal of Thoracic Oncology, and on the editorial board of several other oncology journals. Professor Peters is active in the educational programs of the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC), notably working as the current editor of the ESMO lung cancer clinical practice guidelines. She is the Chair of ESMO Women for Oncology Committee, and she is the youngest ESMO President-elect ever, for a mandate in 2020-2021. She was also a member of the IASLC board of directors, and acts as vice president of the Swiss Group for Clinical Cancer Research lung group. She received both her doctorate in medicine and PhD from the University Hospital of Lausanne, Switzerland. After completing her clinical education in medical oncology and molecular biology in Switzerland and Italy, Professor Peters has specialized in thoracic tumors, lung cancer, and pleural tumors.

Agenda 2021

Following the great success of the first International Lung Cancer Summit (ILCS), we are delighted to invite you to the 2nd International Lung Cancer Summit (ILCS) in Geneva. Similar to 2019, the ILCS will showcase recent discoveries and advances performed towards the treatment of lung cancer. The conference will leverage digital channels to provide with an exceptional outreach and opportunity for delegates from Medical Offices, Universities and Institutes to interact with world-class Medical Oncologists and Industry Professionals working in the field of lung cancer treatment and research. The ILCS constitutes an ideal platform to share knowledge and seamless treatment procedures with our local and international speakers from the USA, Spain, France, UK and Switzerland.

Friday, October 08 2021


Registration & coffee


Welcome by Chairs

A. Addeo & S. Peters


Latest treatment updates for frontline non-oncogene addicted NSCLC

A. Calles


Personalized medicine with Immunotherapy: can we tailor options to patients?

H. Borghaei


Integrating immunotherapy into localized NSCLC

G. Banna


Open discussion & coffee break


Current standard of care and challenges in Small Cell Lung Cancer

A. Curioni


The art of balance: how to manage immune related AEs beyond steroids

R. van Eeden
South Africa




State of the art in biopsy testing: the paths we set for lung cancer treatment

S. Finn


EGFR+ and BRAF: the latest in targeting these driver mutations

V. Noronha


ALK+ and ROS1: what TKI is suitable for what patient?

M. Früh


Open discussion & coffee break


KRAS and HER2: Expanding the horizons for the treatment of lung cancer

C. Lovly


RET, MET, NTRK: a new era for targeted therapies

J. Naidoo


Final Questions & Wrap Up

A. Addeo & S. Peters

This contact form is available only for logged in users.

The Speakers

Alex Friedlaender, MD

University Hospital Geneva

Aurelius Omlin, MD

Cantonal Hospital St. Gallen

Cora Sternberg, MD

Weill Cornell & NY-Presbyterian Hospital
New York, USA


Christine M. Lovly, MD-PhD

Vanderbilt University Medical Center Nashville, Tennessee, USA


Alessandra Curioni, MD

University Hospital Zurich


Antonia Digklia, MD

University Hospital Lausannea


Dominik Berthold, MD

University Hospital Lausanne


Elizabeth Plimack, MD

Fox Chase Cancer Center
Philadelphia, Pennsylvania, USA


Olivier Michielin, MD-PhD

University Hospital Lausanne


Joshua Bauml, MD-PhD

University Hospital Pennsylvania
Philadelphia, Pennsylvania, USA

Our Partners

This series of OncoViews LIVE was made possible with the kind support by:

Eli Lilly Logo
MSD Logo
Amgen Logo
AstraZeneca Logo


Will I be able to re-access the videos?
Yes, absolutely. The content is recorded and made available within 24 hours on our portal so that you can play it on demand as often as you like.
Does it cost me anything?

Access to the debates are completely free! Access to our round-table portal is free of charge for healthcare professionals, students, scientists or other staff from universities, hospitals & research labs as well as policy & non-profit organisations and sponsoring partners. Only registrations by non-sponsoring industry representatives are subject to a fee.

Why do you need my details for registration?

In accordance with Swiss and European regulations, we require some information about you for verification purposes to ensure that the content of our initiatives is aimed at healthcare professionals and those involved in the science, management and treatment of cancer. We will not share your personal details with any sponsor or any third party – promised!

How can I get involved in the discussion?

During the live webinar, you may submit your questions to our panel of experts and with that interact and influence the discussion.








Save the Date and join us for Lung Cancer Summit 2021! Registration opens on (update the date).

Follow Us For The Latest News